FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040352541> ?p ?o ?g. }

• W2040352541 endingPage "29910" @default.
• W2040352541 startingPage "29901" @default.
• W2040352541 abstract "The MLL CXXC domain binds nonmethylated CpG-containing DNA and is essential for the oncogenic properties of MLL fusion proteins. To determine potential functional promiscuity of similar DNA binding domains, we replaced the MLL CXXC domain in the context of the leukemogenic MLL-AF9 fusion with CXXC domains from DNMT1, CGBP (CFP1), and MBD1, or with a methyl-CpG-binding domain (MBD) from MBD1. MLL(DNMT1 CXXC)-AF9 shows robust in vitro colony forming activity and in vivo leukemogenesis, similar to MLL-AF9. However, colony forming ability and leukemogenicity are abrogated in MLL-AF9 containing either the CGBP or MBD1 CXXC domains or the MBD1 MBD domain. Direct comparison of in vitro DNA binding affinity of the isolated CXXC or MBD domains demonstrated that MLL, DNMT1, and CGBP CXXC domains could each bind to unmethylated DNA but with differing affinity. In contrast, the isolated MBD1 CXXC and MBD1 MBD domains were unable to bind to the same DNA. However, all substituted domains still allowed targeting of the MLL fusions to the functionally important Hoxa9 locus in primary bone marrow progenitor cells. In addition to DNA binding activity, it was critical that specific CpG residues in the Hoxa9 locus were protected from methylation for leukemia development. This ultimately prevented histone 3 lysine 9 trimethylation (H3K9me3) of the locus and enabled Hoxa9 expression. These were properties shared by MLL and DNMT1 CXXC domains but not by CGBP CXXC or the other swapped fusions tested. We demonstrate that similar CXXC domains can be mechanistically distinguished by specificity of CpG nucleotides preferentially protected from DNA methylation.Background: The non-methyl-CpG DNA-binding CXXC domain is critical for MLL leukemia.Results: Only the DNMT1 CXXC domain substitutes in an MLL leukemia model because of similar capacity to protect from CpG DNA methylation and H3K9 methylation.Conclusion: Differential protection from specific CpG DNA methylation mechanistically distinguishes similar CXXC domains.Significance: CXXC domains have specific nonredundant activities that impact downstream regulatory functions. The MLL CXXC domain binds nonmethylated CpG-containing DNA and is essential for the oncogenic properties of MLL fusion proteins. To determine potential functional promiscuity of similar DNA binding domains, we replaced the MLL CXXC domain in the context of the leukemogenic MLL-AF9 fusion with CXXC domains from DNMT1, CGBP (CFP1), and MBD1, or with a methyl-CpG-binding domain (MBD) from MBD1. MLL(DNMT1 CXXC)-AF9 shows robust in vitro colony forming activity and in vivo leukemogenesis, similar to MLL-AF9. However, colony forming ability and leukemogenicity are abrogated in MLL-AF9 containing either the CGBP or MBD1 CXXC domains or the MBD1 MBD domain. Direct comparison of in vitro DNA binding affinity of the isolated CXXC or MBD domains demonstrated that MLL, DNMT1, and CGBP CXXC domains could each bind to unmethylated DNA but with differing affinity. In contrast, the isolated MBD1 CXXC and MBD1 MBD domains were unable to bind to the same DNA. However, all substituted domains still allowed targeting of the MLL fusions to the functionally important Hoxa9 locus in primary bone marrow progenitor cells. In addition to DNA binding activity, it was critical that specific CpG residues in the Hoxa9 locus were protected from methylation for leukemia development. This ultimately prevented histone 3 lysine 9 trimethylation (H3K9me3) of the locus and enabled Hoxa9 expression. These were properties shared by MLL and DNMT1 CXXC domains but not by CGBP CXXC or the other swapped fusions tested. We demonstrate that similar CXXC domains can be mechanistically distinguished by specificity of CpG nucleotides preferentially protected from DNA methylation. Background: The non-methyl-CpG DNA-binding CXXC domain is critical for MLL leukemia. Results: Only the DNMT1 CXXC domain substitutes in an MLL leukemia model because of similar capacity to protect from CpG DNA methylation and H3K9 methylation. Conclusion: Differential protection from specific CpG DNA methylation mechanistically distinguishes similar CXXC domains. Significance: CXXC domains have specific nonredundant activities that impact downstream regulatory functions." @default.
• W2040352541 created "2016-06-24" @default.
• W2040352541 creator A5042374820 @default.
• W2040352541 creator A5042815840 @default.
• W2040352541 creator A5046425794 @default.
• W2040352541 creator A5058775784 @default.
• W2040352541 creator A5059184048 @default.
• W2040352541 creator A5069832725 @default.
• W2040352541 creator A5072764362 @default.
• W2040352541 creator A5090278103 @default.
• W2040352541 date "2013-10-01" @default.
• W2040352541 modified "2023-09-26" @default.
• W2040352541 title "Functional Specificity of CpG DNA-binding CXXC Domains in Mixed Lineage Leukemia" @default.
• W2040352541 cites W1820104986 @default.
• W2040352541 cites W1965787451 @default.
• W2040352541 cites W1975325714 @default.
• W2040352541 cites W1983910249 @default.
• W2040352541 cites W1985171686 @default.
• W2040352541 cites W1985634754 @default.
• W2040352541 cites W1986193321 @default.
• W2040352541 cites W1992048312 @default.
• W2040352541 cites W2010291571 @default.
• W2040352541 cites W2020159234 @default.
• W2040352541 cites W2027913461 @default.
• W2040352541 cites W2037374227 @default.
• W2040352541 cites W2037775998 @default.
• W2040352541 cites W2040464173 @default.
• W2040352541 cites W2064396597 @default.
• W2040352541 cites W2077654571 @default.
• W2040352541 cites W2085092579 @default.
• W2040352541 cites W2093908800 @default.
• W2040352541 cites W2094799740 @default.
• W2040352541 cites W2095184701 @default.
• W2040352541 cites W2104460981 @default.
• W2040352541 cites W2107749421 @default.
• W2040352541 cites W2110726136 @default.
• W2040352541 cites W2118916005 @default.
• W2040352541 cites W2119749554 @default.
• W2040352541 cites W2139401049 @default.
• W2040352541 cites W2155235322 @default.
• W2040352541 cites W2158773950 @default.
• W2040352541 cites W2160461365 @default.
• W2040352541 cites W2161509471 @default.
• W2040352541 cites W2163668223 @default.
• W2040352541 cites W2169800491 @default.
• W2040352541 cites W4238323014 @default.
• W2040352541 cites W4246697467 @default.
• W2040352541 doi "https://doi.org/10.1074/jbc.m113.474858" @default.
• W2040352541 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3795288" @default.
• W2040352541 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23990460" @default.
• W2040352541 hasPublicationYear "2013" @default.
• W2040352541 type Work @default.
• W2040352541 sameAs 2040352541 @default.
• W2040352541 citedByCount "27" @default.
• W2040352541 countsByYear W20403525412013 @default.
• W2040352541 countsByYear W20403525412014 @default.
• W2040352541 countsByYear W20403525412015 @default.
• W2040352541 countsByYear W20403525412016 @default.
• W2040352541 countsByYear W20403525412017 @default.
• W2040352541 countsByYear W20403525412018 @default.
• W2040352541 countsByYear W20403525412019 @default.
• W2040352541 countsByYear W20403525412020 @default.
• W2040352541 countsByYear W20403525412021 @default.
• W2040352541 countsByYear W20403525412022 @default.
• W2040352541 countsByYear W20403525412023 @default.
• W2040352541 crossrefType "journal-article" @default.
• W2040352541 hasAuthorship W2040352541A5042374820 @default.
• W2040352541 hasAuthorship W2040352541A5042815840 @default.
• W2040352541 hasAuthorship W2040352541A5046425794 @default.
• W2040352541 hasAuthorship W2040352541A5058775784 @default.
• W2040352541 hasAuthorship W2040352541A5059184048 @default.
• W2040352541 hasAuthorship W2040352541A5069832725 @default.
• W2040352541 hasAuthorship W2040352541A5072764362 @default.
• W2040352541 hasAuthorship W2040352541A5090278103 @default.
• W2040352541 hasBestOaLocation W20403525411 @default.
• W2040352541 hasConcept C104317684 @default.
• W2040352541 hasConcept C123894998 @default.
• W2040352541 hasConcept C140173407 @default.
• W2040352541 hasConcept C150194340 @default.
• W2040352541 hasConcept C153911025 @default.
• W2040352541 hasConcept C175211621 @default.
• W2040352541 hasConcept C190727270 @default.
• W2040352541 hasConcept C2779979206 @default.
• W2040352541 hasConcept C33288867 @default.
• W2040352541 hasConcept C40767141 @default.
• W2040352541 hasConcept C41091548 @default.
• W2040352541 hasConcept C54355233 @default.
• W2040352541 hasConcept C552990157 @default.
• W2040352541 hasConcept C64927066 @default.
• W2040352541 hasConcept C86803240 @default.
• W2040352541 hasConcept C95444343 @default.
• W2040352541 hasConceptScore W2040352541C104317684 @default.
• W2040352541 hasConceptScore W2040352541C123894998 @default.
• W2040352541 hasConceptScore W2040352541C140173407 @default.
• W2040352541 hasConceptScore W2040352541C150194340 @default.
• W2040352541 hasConceptScore W2040352541C153911025 @default.
• W2040352541 hasConceptScore W2040352541C175211621 @default.
• W2040352541 hasConceptScore W2040352541C190727270 @default.

• next